| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |